Although a small number of the vast array of animal long non-coding RNAs (lncRNAs) have known effects on cellular processes examined in vitro, the extent of their contributions to normal cell ...processes throughout development, differentiation and disease for the most part remains less clear. Phenotypes arising from deletion of an entire genomic locus cannot be unequivocally attributed either to the loss of the lncRNA per se or to the associated loss of other overlapping DNA regulatory elements. The distinction between cis- or trans-effects is also often problematic. We discuss the advantages and challenges associated with the current techniques for studying the in vivo function of lncRNAs in the light of different models of lncRNA molecular mechanism, and reflect on the design of experiments to mutate lncRNA loci. These considerations should assist in the further investigation of these transcriptional products of the genome.
The aim of this study was to compare outcomes of infants pre and post initiation of a feeding protocol providing an exclusive human milk-based diet (HUM).
In a multicenter retrospective cohort study, ...infants with a birth weight <1,250 g who received a bovine-based diet (BOV) of mother's own milk fortified with bovine fortifier and/or preterm formula were compared to infants who received a newly introduced HUM feeding protocol. Infants were excluded if they had major congenital anomalies or died in the first 12 hours of life. Data were collected 2-3 years prior to and after introduction of an exclusive HUM diet. Primary outcomes were necrotizing enterocolitis (NEC) and mortality. Secondary outcomes included late-onset sepsis, retinopathy of prematurity (ROP), and bronchopulmonary dysplasia (BPD).
A total of 1,587 infants were included from four centers in Texas, Illinois, Florida, and California. There were no differences in baseline demographics or growth of infants. The HUM group had significantly lower incidence of proven NEC (16.7% versus 6.9%, p < 0.00001), mortality (17.2% versus 13.6%, p = 0.04), late-onset sepsis (30.3% versus 19.0%, p < 0.00001), ROP (9% versus 5.2%, p = 0.003), and BPD (56.3% versus 47.7%, p = 0.0015) compared with the BOV group.
Extremely premature infants who received an exclusive HUM diet had a significantly lower incidence of NEC and mortality. The HUM group also had a reduction in late-onset sepsis, BPD, and ROP. This multicenter study further emphasizes the many benefits of an exclusive HUM diet, and demonstrates multiple improved outcomes after implementation of such a feeding protocol.
•The ricin vaccine RVEc™ was safe and well tolerated at 20- and 50-μg doses.•Creatine phosphokinase levels were elevated in two subjects receiving 100μg RVEc™.•100% of subjects at the 20- and 50-μg ...doses achieved ELISA anti-ricin IgG titers of 1:500 to 1:121,500.•50% of subjects at the 20- and 50-μg doses produced neutralizing anti-ricin antibodies.•A single 50-μg booster elicited robust anamnestic ELISA antibody responses and boosted the neutralizing anti-ricin antibody responses in 100% of vaccinees.
Ricin is a potent toxin and potential bioterrorism weapon for which no specific licensed countermeasures are available. We report the safety and immunogenicity of the ricin vaccine RVEc™ in a Phase 1 (N=30) multiple-dose, open-label, non-placebo-controlled, dose-escalating (20, 50, and 100μg), single-center study. Each subject in the 20- and 50-μg dose groups (n=10 for each group) received three injections at 4-week intervals and was observed carefully for untoward effects of the vaccine; blood was drawn at predetermined intervals after each dose for up to 1 year. RVEc™ was safe and well tolerated at the 20- and 50-μg doses. The most common adverse events were pain at the injection site and headache. Of the 10 subjects who received a single 100-μg dose, two developed elevated creatine phosphokinase levels, which resolved without sequelae. No additional doses were administered to subjects in the 100-μg group. Immunogenicity of the vaccine was evaluated by measuring antibody response using the well standardized enzyme-linked immunosorbent assay (ELISA) and toxin neutralization assay (TNA). Of the subjects in the 20- and 50-μg dose groups, 100% achieved ELISA anti-ricin IgG titers of 1:500 to 1:121,500 and 50% produced neutralizing anti-ricin antibodies measurable by TNA. Four subjects in the 50-μg group received a single booster dose of RVEc™ 20–21 months after the initial dose. The single booster was safe and well tolerated, resulting in no serious adverse events, and significantly enhanced immunogenicity of the vaccine in human subjects. Each booster recipient developed a robust anamnestic response with ELISA anti-ricin IgG titers of 1:13,500 to 1:121,500 and neutralizing antibody titers of 1:400 to 1:3200. Future studies will attempt to optimize dose, scheduling, and route of administration. This study is registered at clinicaltrials.gov (NCT01317667 and NCT01846104).
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
Space exploration objectives will soon move from low Earth orbit to distant destinations like Moon and Mars. The present work provides an up-to-date roadmap that identifies critical research gaps ...related to human behavior and performance in altered gravity and space. The roadmap summarizes (1) key neurobehavioral challenges associated with spaceflight, (2) the need to consider sex as a biological variable, (3) the use of integrative omics technologies to elucidate mechanisms underlying changes in the brain and behavior, and (4) the importance of understanding the neural representation of gravity throughout the brain and its multisensory processing. We then highlight the need for a variety of target-specific countermeasures, and a personalized administration schedule as two critical strategies for mitigating potentially adverse effects of spaceflight on the central nervous system and performance. We conclude with a summary of key priorities for the roadmaps of current and future space programs and stress the importance of new collaborative strategies across agencies and researchers for fostering an integrative cross- and transdisciplinary approach from cells, molecules to neural circuits and cognitive performance. Finally, we highlight that space research in neurocognitive science goes beyond monitoring and mitigating risks in astronauts but could also have significant benefits for the population on Earth.
•Two year study of hydraulic fracturing debate in the Marcellus Shale region.•Focused on how advocates on both sides legitimized government decision makers.•Both sides sought to legitimize ...state-level legislators and regulators.•Activists favored federal-level intervention as legitimate; the energy industry did not.•Energy industry sought to limit local governments’ ability to ban new wells.
This study examined a two-year period in which natural gas development in the Marcellus Shale region of Pennsylvania expanded rapidly, as did public policy proposals meant to deal with the myriad legal, economic, and environmental issues that accompanied this growth. Focusing on the use of legitimacy strategies during the critical phase of the issue of hydraulic fracturing, the study examined how activists and energy industry advocates argued that different levels of government policy making – local, state, and federal – should be the locus of policy decisions. Both the “fractivists” and the energy industry sought to legitimize state-level legislators and regulators. Activists viewed federal-level intervention as legitimate leverage for their work in the state, while the energy industry saw federal regulators as redundant and restrictive. Finally, while both sides viewed local authorities as legitimate actors, the energy industry sought to limit their ability to act against the development of new wells.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
To determine the impact of continuous positive airway pressure (CPAP) on weight change in persons with obstructive sleep apnea (OSA).
The Apnea Positive Pressure Long-term Efficacy Study (APPLES) was ...a 6-month, randomized, double-blinded sham-controlled multicenter clinical trial conducted at 5 sites in the United States. Of 1,105 participants with an apnea hypopnea index ≥ 10 events/ hour initially randomized, 812 had body weight measured at baseline and after 6 months of study.
CPAP or Sham CPAP.
Body weight, height, hours of CPAP or Sham CPAP use, Epworth Sleepiness Scale score.
Participants randomized to CPAP gained 0.35 ± 5.01 kg, whereas those on Sham CPAP lost 0.70 ± 4.03 kg (mean ± SD, p = 0.001). Amount of weight gain with CPAP was related to hours of device adherence, with each hour per night of use predicting a 0.42 kg increase in weight. This association was not noted in the Sham CPAP group. CPAP participants who used their device ≥ 4 h per night on ≥ 70% of nights gained the most weight over 6 months in comparison to non-adherent CPAP participants (1.0 ± 5.3 vs. -0.3 ± 5.0 kg, p = 0.014).
OSA patients using CPAP may gain a modest amount of weight with the greatest weight gain found in those most compliant with CPAP.
A commentary on this article appears in this issue on page 995.
Quan SF; Budhiraja R; Clarke DP; Goodwin JL; Gottlieb DJ; Nichols DA; Simon RD; Smith TW; Walsh JK; Kushida CA. Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea.
Extensive atherosclerotic plaque burden in the lower extremities often leads to symptomatic peripheral artery disease (PAD) including impaired walking performance and claudication. Interleukin-1β ...(IL-1β) may play an important pro-inflammatory role in the pathogenesis of this disease. Interruption of IL-1β signaling was hypothesized to decrease plaque progression in the leg macrovasculature and improve the mobility of patients with PAD with intermittent claudication. Thirty-eight patients (mean age 65 years; 71% male) with symptomatic PAD (confirmed by ankle–brachial index) were randomized 1:1 to receive canakinumab (150 mg subcutaneously) or placebo monthly for up to 12 months. The mean vessel wall area (by 3.0 T black-blood magnetic resonance imaging (MRI)) of the superficial femoral artery (SFA) was used to measure plaque volume. Mobility was assessed using the 6-minute walk test. Canakinumab was safe and well tolerated. Markers of systemic inflammation (interleukin-6 and high-sensitivity C-reactive protein) fell as early as 1 month after treatment. MRI (32 patients at 3 months; 21 patients at 12 months) showed no evidence of plaque progression in the SFA in either placebo-treated or canakinumab-treated patients. Although an exploratory endpoint, placebo-adjusted maximum and pain-free walking distance (58 m) improved as early as 3 months after treatment with canakinumab when compared with placebo. Although canakinumab did not alter plaque progression in the SFA, there is an early signal that it may improve maximum and pain-free walking distance in patients with symptomatic PAD. Larger studies aimed at this endpoint will be required to definitively demonstrate this. ClinicalTrials.gov Identifier: NCT01731990
Full text
Available for:
NUK, OILJ, SAZU, UKNU, UL, UM, UPUK
Highlights ► Bilateral vestibular lesion induces anxiety, spatial memory impairments, and hyperactivity in rat. ► The black and white box test is an ideal test in bilabyrinthectomized rat. ► Anxiety ...does not participate in spatial memory impairments related to loss of vestibular system in rat.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
The development of the structure–activity studies leading to the discovery of anacetrapib is described. These studies focused on varying the substitution of the oxazolidinone ring of the ...5-aryloxazolidinone system. Specifically, it was found that substitution of the 4-position with a methyl group with the cis-stereochemistry relative to the 5-aryl group afforded compounds with increased cholesteryl ester transfer protein (CETP) inhibition potency and a robust in vivo effect on increasing HDL-C levels in transgenic mice expressing cynomolgus monkey CETP.
Establishing a coherent internal reference frame for visuospatial representation and maintaining the integrity of this frame during eye movements are thought to be crucial for both perception and ...motor control. A stable headcentric representation could be constructed by internally comparing retinal signals with eye position. Alternatively, visual memory traces could be actively remapped within an oculocentric frame to compensate for each eye movement. We tested these models by measuring errors in manual pointing (in complete darkness) toward briefly flashed central targets during three oculomotor paradigms; subjects pointed accurately when gaze was maintained on the target location (control paradigm). However, when steadily fixating peripheral locations (static paradigm), subjects exaggerated the retinal eccentricity of the central target by 13.4 +/- 5.1%. In the key "dynamic" paradigm, subjects briefly foveated the central target and then saccaded peripherally before pointing toward the remembered location of the target. Our headcentric model predicted accurate pointing (as seen in the control paradigm) independent of the saccade, whereas our oculocentric model predicted misestimation (as seen in the static paradigm) of an internally shifted retinotopic trace. In fact, pointing errors were significantly larger than were control errors (p </= 0.003) and were indistinguishable (p >/= 0.25) from the static paradigm errors. Scatter plots of pointing errors (dynamic vs static paradigm) for various final fixation directions showed an overall slope of 0.97, contradicting the headcentric prediction (0. 0) and supporting the oculocentric prediction (1.0). Varying both fixation and pointing-target direction confirmed that these errors were a function of retinotopically shifted memory traces rather than eye position per se. To reconcile these results with previous pointing experiments, we propose a "conversion-on-demand" model of visuomotor control in which multiple visual targets are stored and rotated (noncommutatively) within the oculocentric frame, whereas only select targets are transformed further into head- or bodycentric frames for motor execution.
PDF
